| 序号 |
标题 |
次数 |
作者 |
发布时间 |
| 77086 |
GG-Tesirine，ADC定制 |
128 |
wyh |
2024-12-19 |
| 77087 |
DOTA-PEG-A20FMDV2 DOTA偶联聚乙二醇化的20个残基的线性肽 |
158 |
h |
2024-12-19 |
| 77088 |
MC-GGFG-Exatecan，ADC定制 |
160 |
wyh |
2024-12-19 |
| 77089 |
亲和素-AMF-DOTA(Nd) |
111 |
h |
2024-12-19 |
| 77090 |
DOTA偶联人血清白蛋白微球 DOTA-HSAM |
184 |
h |
2024-12-19 |
| 77091 |
MC-VA-PBD，MC-Val-Ala-PBD，ADC定制 |
215 |
wyh |
2024-12-19 |
| 77092 |
cas:2241685-22-1，DADPS Biotin Alykne |
106 |
zyl |
2024-12-19 |
| 77093 |
MC-vc-PAB-C6-Alpha-Amanitin，ADC定制 |
91 |
wyh |
2024-12-19 |
| 77094 |
MPB-MMAF，ADC定制 |
142 |
wyh |
2024-12-19 |
| 77095 |
DOTA–Bipy–RuII配位共轭物 |
178 |
h |
2024-12-19 |
| 77096 |
cas:1007215-91-9，1-(4-formylphenyl)-1-oxo-5,8,11-trioxa-2-azatridecan-13-oic acid |
132 |
zyl |
2024-12-19 |
| 77097 |
DOTA-cT84.66 DOTA偶联单克隆抗体cT84.66 |
97 |
h |
2024-12-19 |
| 77098 |
DOTA-Ahx-(D-Lys(6)-GnRH1)金属螯合剂DOTA偶联氨基己酸缀合D-赖氨酸 |
101 |
h |
2024-12-19 |
| 77099 |
DOTA-LRB 2-(6-(二乙基氨基)-3-(二乙基亚胺基)-3H-呫吨-9-基)-5-(N-(2-(2-(4,7,10-三(羧甲基)-1,4,7,10-四氮杂环十二烷-1-基)乙酰胺基 |
112 |
h |
2024-12-19 |
| 77100 |
DOTA-Y3-TATE DOTA偶联激动剂Y3-TATE |
105 |
h |
2024-12-19 |
| 77101 |
DOTA-2-脱氧-D-氨基葡萄糖 DOTA-DG |
142 |
h |
2024-12-19 |
| 77102 |
DOTA-c(RGDfK)DOTA偶联环肽 |
96 |
h |
2024-12-19 |
| 77103 |
SCN-DOTA-PCA DOTA-苯甲酰胺衍生物 |
123 |
h |
2024-12-19 |
| 77104 |
DOTA-N-羟基琥珀酰亚胺 DOTA-N-hydroxysuccinimide |
100 |
h |
2024-12-19 |
| 77105 |
低分子量CLT1肽靶向Gd(III)螯合物CLT1-dL-(Gd-DOTA) |
178 |
h |
2024-12-19 |
| 77106 |
DOTA-1,2-二硬脂酰-sn-甘油-3-磷酸乙醇胺脂质 |
163 |
h |
2024-12-19 |
| 77107 |
1,4,7-三氮杂环壬烷-1,4,7-三乙酸(NOTA17,19) |
112 |
h |
2024-12-19 |
| 77108 |
cas:1061569-06-9，4-formyl-N-(2-(2-hydroxyethoxy)ethyl)benzamide ADC抗体偶联药物 |
91 |
zyl |
2024-12-19 |
| 77109 |
DBCO-PEG4-VA-PBD，2241644-09-5，ADC定制 |
86 |
wyh |
2024-12-19 |
| 77110 |
Val-Cit-PAB-MMAE，cas:644981-35-1，ADC定制 |
97 |
wyh |
2024-12-19 |
| 77111 |
DOTA-GMSH 1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸(DOTA)偶联α-黑素细胞刺激素(α-MSH)类似物 |
113 |
h |
2024-12-19 |
| 77112 |
mDPR-Val-Cit-PAB-MMAE，1491152-26-1，ADC定制 |
95 |
wyh |
2024-12-19 |
| 77113 |
G3-(Gd-DTPA)(24)DOTA-钆(Gd)大分子造影剂 |
199 |
h |
2024-12-19 |
| 77114 |
DOTA-多柔比星 DOTA-DOX |
122 |
h |
2024-12-19 |
| 77115 |
聚(HPMA)-c(RGDyK)-DOTA |
78 |
h |
2024-12-19 |
| 77116 |
1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸(DOTA)螯合剂共轭的应变环辛烯衍生物二苄基环辛烯(DBCO) |
102 |
h |
2024-12-19 |
| 77117 |
PDDEC-NB；2-methyl-2-(pyridin-2-yldisulfanyl)propyl 4-nitrophenyl carbonate |
85 |
zyl |
2024-12-19 |
| 77118 |
(67)Ga-DOTA复合物共轭二膦酸盐(67)Ga-DOTA-Bn-SCN-HBP |
119 |
h |
2024-12-19 |
| 77119 |
MWCNT/PEI-FI-DOTA(Gd)-PEG 异硫氰酸荧光素(FI)和钆(Gd)螯合剂共价接枝聚乙烯亚胺修饰的多壁碳纳米管 |
127 |
h |
2024-12-19 |
| 77120 |
DOTA-Cys-hAb47 螯合剂DOTA偶联半胱氨酸-抗EphB4抗体hAb47和hAb131 |
170 |
h |
2024-12-19 |
| 77121 |
1,4,7,10-四氮杂环十二烷-N,N,N,N-四乙酸(DOTA)-F(ab)2-曲妥珠单抗 |
91 |
h |
2024-12-19 |
| 77122 |
DOTA-MG11(DOTA-DGlu-Ala-Tyr-Gly-Trp-Met-Asp)DOTA肽缀合物 |
123 |
h |
2024-12-19 |
| 77123 |
AcLys-PABC-VC-Aur0101， cas:1438851-17-2，ADC定制 |
149 |
wyh |
2024-12-19 |
| 77124 |
cas:107348-47-0，2,5-dioxopyrrolidin-1-yl 3-(pyridin-2-yldisulfanyl)butanoate ADC抗体偶联药物 |
81 |
zyl |
2024-12-19 |
| 77125 |
SMCC-DM4 ， cas:1228105-52-9，ADC定制 |
86 |
wyh |
2024-12-19 |
| 77126 |
cas:1639939-40-4 Mal-Val-Ala-PAB-PNP |
93 |
zyl |
2024-12-19 |
| 77127 |
MA-PEG8-VA-PAB-SG3199，ADC定制 |
115 |
wyh |
2024-12-19 |
| 77128 |
Acid-PEG4-Val-Cit-PAB-MMAE |
82 |
zyl |
2024-12-19 |
| 77129 |
MC-Val-Cit-PAB-Indibulin，cas:2055896-95-0，ADC定制 |
91 |
wyh |
2024-12-19 |
| 77130 |
cas:1096584-62-1 Mal-Val-Cit-PAB-PNP |
96 |
zyl |
2024-12-19 |
齐岳微信公众号
官方微信
库存查询